NCT03899961View on ClinicalTrials.gov

Carbetocin Myocardium Trial 2014 Part 2

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

March 1, 2022

Study Completion Date

April 15, 2022

Conditions
Pregnancy Complications
Interventions
DRUG

Oxytocin

Oxytocin 2.5 U i.v.

DRUG

Carbetocin

Carbetocin 100 µg i.v.

Trial Locations (2)

Unknown

Akershus University Hospital, Lørenskog

0027

Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet, Oslo

All Listed Sponsors
collaborator

University Hospital, Akershus

OTHER

lead

Oslo University Hospital

OTHER

NCT03899961 - Carbetocin Myocardium Trial 2014 Part 2 | Biotech Hunter | Biotech Hunter